VOLUME 1
Part 1: Assessment of the patient with renal disease
1: Aminu K. Bello, Marcello Tonelli, and Kitty J. Jager: Epidemiology of kidney disease
2: Chris Winearls: Clinical assessment of the patient with renal disease
3: Chris Winearls: Presentations of renal disease
4: Chris Winearls: Kidney disease focused history taking
5: Chris Winearls: Kidney disease focused features on examination
6: Walter P. Mutter: Urinalysis
7: Walter P. Mutter: Assessment of renal function
8: Walter P. Mutter: Tubular function
9: Michael Weston: Renal radiology: overview
10: Jeannette Kathrin and Peter Howells: Ionising radiation and radiation protection
11: Akira Kawashima and Andrew J. LeRoy: Plain radiography, excretion radiography, and contrast radiography
12: Steven Kennish: Intervention
13: Toby Wells and Simon Freeman: Ultrasound
14: Eugene Teoh and Michael Weston: Computed tomography
15: Kazuhiro Kitajima, Akira Kawashima. and James F Glockner: Magnetic Resonance Imaging
16: Ramya Dhandapani and Sobhan Vinjamuri: Radioisotopes in diagnostic imaging in nephrology
17: Jo H.M. Berden and Jack Wetzels: Immunological investigation of the patient with renal disease
18: Ian Roberts, Phil Mason and Agnes Fogo: The renal biopsy
19: Richard Haynes, Martin J Landry, William G Herrington, and Colin Baigent: Clinical trials- how and why in nephrology
Part 2: The patient with fluid, electrolyte, and renal tubular disorders
20: Matthew A. Bailey: An overview of tubular function
21: Laurent Schild: Sodium transport and balance: A key role for the distal nephron
22: David Marples and Soren Neilson: Water homeostasis
23: Alain Doucet and Gilles Crambert: Potassium homeostasis
24: Carsten Wagner and Olivier Devuyst: Renal acid-base homeostasis
25: Heini Murer, Juerg Biber, and Carsten Wagner: Phosphate homeostasis
26: Francesco Trepiccione and Gianni Capasso: Calcium homeostasis
27: Pascal Houillier: Magnesium homeostasis
28: Ewout Hoorn and Bob Zietse: Approach to the patient with hyponatraemia
29: Bob Zietse: Approach to the patient with hypernatraemia
30: Jean-Marie Krzesinski and Eric P. Cohen: Approach to the patient with oedema
31: Detlef Bockenhauer and Robert Kleta: Approach to the patient with salt-wasting
32: Daniel Bichet: Approach to the patient with polyuria
33: David Ellison and Arohan R. Subramanya: Clinical use of diuretics
34: Charles Wingo and I. David Weiner: Approach to the patient with hypo-/hyperkalaemia
35: Mitch Halperin and Kamel Kamel: Approach to the patient with metabolic acidosis or alkalosis
36: Stephen Walsh: Approach to the patient with renal tubular acidosis
37: Dennis Jose Joseph and Theresa A. Guise: Approach to the patient with hypercalcaemia
38: Agnes Linglart and Anne-Sophie Lambert: Approach to the patient with hypocalcaemia
39: Judith Blaine, Hector Giral-Arnal, Sabina Jelen, and Moshe Levi: Approach to the patient with hypo-/hyperphosphataemia
40: Martin Konrad and Karl Peter Schlingmann: Approach to the patient with hypomagnesaemia
41: Detlef Bockenhauer and Robert Kleta: Approach to the patient with renal Fanconi syndrome, glycosuria or aminoaciduria
Part 3: The patient with glomerular disease
42: Alexander Woywodt and Diana Chiu: The glomerulus and the concept of glomerulonephritis
43: Marlies Elger and Wilhelm Kriz: The renal glomerulus - the structural basis of ultrafiltration
44: Jean-Claude Dussaule, Martin Flamant, and Christos Chatziantoniou: Function of the normal glomerulus
45: Neil Turner: Mechanisms of glomerular injury: overview
46: John Neary and Neil Turner: The patient with haematuria
47: John Neary: Loin pain haematuria syndrome
48: John Neary and Neil Turner: Nutcracker syndrome and phenomenon
49: Neil Turner: Exercise-related pseudonephritis
50: Neil Turner and Stewart Cameron: Proteinuria
51: Neil Turner: Postural proteinuria (Benign orthostatic proteinuria)
52: Premil Rajakrishna, Stewart Cameron and Neil Turner: Nephrotic syndrome
53: Neil Turner and Premil Rajakrishna: Pathophysiology of oedema in nephrotic syndrome
54: Patrick Niaudet and Alain Meyrier: Idiopathic nephrotic syndrome: overview
55: Patrick Niaudet and Alain Meyrier: Minimal change disease: clinical features and diagnosis
56: Patrick Niaudet and Alain Meyrier: Minimal change disease: treatment and outcome
57: Patrick Niaudet and Alain Meyrier: Primary focal segmental glomerulosclerosis (FSGS): Clinical features and diagnosis
58: Patrick Niaudet and Alain Meyrier: Primary focal segmental glomerulosclerosis (FSGS): Treatment and outcome
59: Patrick Niaudet and Alain Meyrier: Pathogenesis of proteinuria in minimal change disease and FSGS
60: Daniel Cattran and Heather Reich: Membranous glomerulonephritis: overview
61: Daniel Cattran and Heather Reich: Membranous glomerulonephritis: clinical features and diagnosis
62: Daniel Cattran and Heather Reich: Membranous glomerulonephritis: treatment and outcome
63: Daniel Cattran and Heather Reich: Secondary membranous glomerulonephritis
64: Daniel Cattran and Heather Reich: Membranous glomerulonephritis: pathogenesis
65: Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: overview
66: Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: clinical features
67: Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: diagnosis
68: Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: treatment and outcome
69: Kar Nen Lai and Sydney C. W. Tang: Immunoglobulin A nephropathy: pathogenesis
70: Neil Turner: Crescentic (rapidly progressive) glomerulonephritis
71: Ciao Zhou, Neil Turner, and Ming-hui Zhao: Anti-glomerular basement membrane disease: overview
72: Ciao Zhou, Neil Turner, and Ming-hui Zhao: Anti-glomerular basement membrane disease: clinical features and diagnosis
73: Ciao Zhou, Neil Turner, and Ming-hui Zhao: Anti-glomerular basement membrane disease: treatment and outcome
74: Ciao Zhou, Neil Turner, and Ming-hui Zhao: Antiglomerular basement membrane disease: pathogenesis
75: Neil Turner: Alport post-transplant antiglomerular basement membrane disease
76: Bernardo Rodriguez-Iturbe and Mark Haas: Post-infectious glomerulonephritis: overview
77: Bernardo Rodriguez-Iturbe and Mark Haas: Post streptococcal glomerulonephritis
78: Bernardo Rodriguez-Iturbe and Mark Haas: Immunoglobulin A dominant post-infectious glomerulonephritis
79: Bernardo Rodriguez-Iturbe and Mark Haas: Glomerulonephritis associated with endocarditis, deep-seated infections and shunt nephritis
80: T. Cook and Daniel Gale: Membranoproliferative glomerulonephritis and C3 glomerulopathy
81: Stephen Korbet, Melvin M.Schwartz, and Edmund J. Lewis: Fibrillary and immunotactoid glomerulopathy
82: Alexander Woywodt and Diana Chiu: Drug induced and toxic glomerulopathies
Part 4: The patient with interstitial disease
83: Richard Baker and B.Chir: Acute tubulointerstitial nephritis: overview
84: Hassan Izzedine and Victor Gueutin: Drug-induced acute tubulointerstitial nephritis
85: Gregory L. Braden and Benjamin J. Freda: Other toxic acute tubulointerstitial nephritis
86: Adalbert Schiller, Adrian Covic, and Liviu Segall: Chronic tubulointerstitial nephritis: overview
87: Hassan Izzedine and Victor Gueutin: Drug-induced chronic tubulointerstitial nephritis
88: Patrick C D'Haese, Benjamin Vervaet, and A Verhulst: Heavy metals-induced tubulointerstitial nephritis
89: Refik Gökmen and Graham Lord: Aristolochic acid nephropathy caused by ingestion of herbal medicinal products
90: Milan Radovic and Adalbert Schiller: Balkan endemic nephropathy
91: Lisa Phipps and David C. Harris: Radiation nephropathy
92: D. H. Kang and M. Kanbay: Urate nephropathy
93: Liviu Segall and Adrian Covic: Immune-mediated tubulointerstitial nephritis
Part 5: The patient with reduced renal function
94: Ashish Upadyhah, Lesley Inker, and Andrew Levey: Chronic kidney disease: definition, classification, and approach to management
95: Morgan Grams and Josef Coresh: Chronic kidney disease in the developed world
96: LuXia Zhang and Haiyan Wang: Chronic kidney disease in developing countries
97: M. Beaulieu, C. Weber, N. Zalunardo and Adeera Levin: Chronic kidney disease long-term outcomes: progression, death, cardiovascular disease, infections, and hospitalizations
98: David Goldsmith: Cardiovascular disease and chronic kidney disease: overview
99: Charles Ferro and Khai Ping Ng: Recommendations for management of high renal risk chronic kidney disease
100: Teena Tandon and Rajiv Agarwal: Hypertension as a cause of chronic kidney disease: what is the evidence?
101: Juan Jesus Carrero, Xu Hong, and Bengt Lindholm: Diet and the progression of chronic kidney disease
102: Alan Jardine and Rajan Patel: Lipid disorders of patients with chronic kidney disease
103: Stephan R. Orth: Smoking in chronic kidney disease
104: Edmund Lamb and Finlay MacKenzie: Analytical aspects of measurements and laboratory values in chronic and acute kidney disease
105: Andrew Williams, Robert Fassett, Erin Howden, and Jeff Coombes: Effect of lifestyle modifications on patients with chronic kidney disease
106: Naveet Kumar, Peter McCulloch, Heather Henderson, and Beverly D. Cameron: Malnutrition, obesity, and undernutrition in chronic kidney disease
107: Carmine Zoccali, Francesca Mallamaci, and Davide Bolignano: Left ventricular hypertrophy in chronic kidney disease
108: Reza Hajhosseini, Kaivan Korvath, and David Goldsmith: Sudden cardiac death in chronic kidney disease
109: Patrick Biggar, Hansjoerg Rothe, and Markus Ketteler: Epidemiology of calcium, phosphate and PTH disturbances in chronic kidney disease
110: Juan Jesus Carrero and Peter Stenvinkel: The role of inflammation in chronic kidney disease
111: John Townend and Charles Ferro: Vascular stiffness in chronic disease - pathophysiology and implications
112: Nostratoli Vaziri: Oxidative stress and its implications in chronic disease
113: Thimoteus Speer and Danilo Fliser: Abnormal endothelial vasomotor and secretory function
114: Neeraj Dhaun and David Webb: Endothelins and their antagonists in chronic kidney disease
115: Stuart Sprague and Menaka Sarav: Chronic kidney disease-mineral and bone disorder: overview
116: Paulo Raggi and Luis D'Marco Gascon: Imaging for detection of vascular disease in chronic kidney disease patients
117: Alexandra Voinescu, Nadia Iqbal and Kevin Martin: Pathophysiology of chronic kidney disease - mineral and bone disorder
118: Alexandra Voinescu, Kevin Martin, Nadia Iqbal, and David Goldsmith: Management of chronic kidney disease - mineral and bone disorder
119: Orlando Gutierrez: Fibroblast growth factor 23, klotho, and phosphorus metabolism in chronic kidney disease
120: Adrian Covic, Mugurel Apetrii, Luminita Voroneanu, and David Goldsmith: Vascular calcification
121: Alastair Hutchison and Michael L. Picton: Fractures in patients with chronic kidney disease
122: Stuart Sprague and James Pullman: Spectrum of bone pathologies in chronic kidney disease
123: Iain Macdougall: Clinical aspects and overview of renal anaemia
124: Iain Macdougall and Jolanta Malyszko: Erythropoiesis-stimulating agents in chronic kidney disease
125: Jolanta Malyszko and Iain Macdougall: Iron metabolism in chronic kidney disease
126: Iain Macdougall: Iron management in renal anaemia
127: Kaivan Khavandi, Halima Amer, Sarah Withers, and Behdad Afzali: Pleoitropic effects of Vitamin D
128: Behdad Afzali and Claudia Kemper: Immunity
129: Fabrizio Fabrizi and Michel Jadoul: The liver and chronic kidney disease
130: Rishi Goel, Kamal Patel, and Terry Wong: Gastroenterology and renal medicine
131: Timur A. Galperin, Kieron S. Leslie, and Antonia J. Cronin: Cutaneous manifestations of end-stage renal disease (ESRD)
132: Tomas Agustsson and Paul Carroll: The patient with reduced renal function: endocrinology
133: Tomas Agustsson and Paul Carroll: Sexual dysfunction
134: Fred Finkelstein and Susan Finkelstein: Health related quality of life and the patient with chronic kidney disease
135: Seema Shrivastava, Beverley Hunt, and Tony Dorling: Coagulopathies in chronic kidney disease
136: Neil Turner: Mechanisms of progression of chronic kidney disese- overview
137: Jeremy Hughes: Proteinuria as a direct cause of progression
138: Valerie Luyckx: Nephron numbers and hyperfiltration as drivers of progression
139: Wilhelm Kriz: Podocyte loss as a common pathway to chronic kidney disease
140: Jeremy Duffield: Disordered scarring and failure of repair
141: Raj Thuraisingham and Cormac Breen: Modality selection for renal replacement therapy
142: Sue Cox and Nicola Thomas: Patient education and involvement in pre-dialysis management
143: Muh Geot Wong, Bruce A. Cooper, and Carol A. Pollock: Preparation for renal replacement therapy
144: Karthik Tennankore and Chris Chan: Choices and considerations for in-centre versus home based renal replacement therapy
145: Aine Burns and Fliss E.M. Murtagh: Conservative care in advanced chronic kidney disease
146: Katie Vinen, Fliss E.M. Murtagh, and Irene Higginson: Palliative care in end stage renal disease
147: Bernadette Thomas and Christopher Blagg: Patient selection when resources are limited
148: Muhammad Magdi Yaqoob: Acidosis in chronic kidney disease
VOLUME 2
Part 6: The patient with another primary diagnosis
149: Luigi Gnudi, Giorgio Gentile, and Piero Ruggenenti: The patient with diabetes mellitus
150: Pierre M. Ronco: Kidney involvement in plasma cell dyscrasias
151: Fabrizio Fabrizi and Patrice Cacoub: The patient with cryoglobulinaemia
152: Helen J. Lachmann and Giampaolo Merlini: The patient with amyloidosis
153: Efstathios Kastritis and M. A. Dimopoulos: The patient with myeloma
154: Dirk R. J. Kuypers and Morie A. Gertz: Light chain deposition disease
155: Fernardo Fervenza, S. Vincent Raj Kumar, and Sethi Sanjeev: Other consequences from monoclonal immunoglobulins/fragments: Membranoproliferative Glomerulonephritis and Acquired Fanconi Syndrome
156: Ravi Rajakaria and Muhammad Magdi Yaqoob: The patient with sarcoidosis
157: David Jayne: The patient with vasculitis- overview
158: Peter Heeringa and Coen A. Stegeman: The patient with vasculitis: pathogenesis
159: Alan Salama: The patient with vasculitis: clinical aspects
160: Lorraine Harper and David Jayne: The patient with vasculitis: treatment and outcome
161: Johan van der Vlag and Jo H.M. Berden: The patient with systemic lupus erythematosus: overview and pathogenesis
162: Marie Condon, Philippa Dodd, and Liz Lightstone: The patient with systemic lupus erythematosus: clinical features, investigations, and diagnosis
163: Frederic Houssiau: The patient with systemic lupus erythematosus: treatment and outcome
164: Bassam Alchi and David Jayne: The patient with antiphospholipid syndrome with or without lupus
165: Aine Burns and Bernadette Lynch: The patient with scleroderma-systemic sclerosis
166: Lesley-Anne Bissell, Dwomoa Adu, and Paul Emery: The patient with rheumatoid arthritis, mixed connective tissue disease, polymyositis, Sjögren syndrome, or overlap syndrome
167: Jean-Philippe Haymann and François Lionnet: The patient with sickle cell anemia
168: Maarit Korkeila, Bengt Lindholm, and Peter Stenvinkel: The obese patient (metabolic syndrome)
169: Andres Cardenas and Pere Ginès: The patient with hepatorenal syndrome
170: Paul Goodyer: Kidney/ear syndromes
171: Friederike Mackensen, Vedat Schwenger, and Heiko Billing: Kidney/eye syndromes
172: Tim Eisen: The patient with renal cell cancer
173: Christopher D. Mitchell: The patient with Wilms' tumour
174: Marina Noris and Tim Goodship: The patient with haemolytic uraemic syndrome/thrombotic thrombocytopenic purpura
Part 7: The patient with urinary tract infection
175: Neil Sheerin: Urinary tract infection in the adult: overview
176: Ased Ali and Rob Pickard: Infection of the lower urinary tract
177: Mark Harber: Upper urinary tract infection
178: Ased Ali and Rob Pickard: Complicated urinary tract infection
179: Mark Harber: Urinary tract infection in a patient with a kidney transplant
180: Heather Lambert: Urinary tract infection in infancy and childhood
181: Rashad Barsoum: Schistosomiasis: the parasite and the host
182: Rashad Barsoum: Schistosomiasis: clinical impact
Part 8: The patient with infections causing renal disease
183: Vinay Sakhuja and Harbir Singh Kohli: Malaria
184: Vinay Sakhuja and Harbir Singh Kohli: Leishmaniasis and trypanosomiasis
185: Marion Muche and Seema Baid-Agrawal: Hepatitis B
186: Fabrizio Fabrizi: Hepatitis C
187: Saraladevi Naicker and Graham Paget: HIV and renal disease
188: Hung-Chun Chen and Jan Clement: Hantaviral infections
189: Jung-San Chang and Hung-Chun Chen: Dengue and other viral haemorrhagic fevers
190: Norbert Lameire: Yellow fever, severe acute respiratory syndrome virus, and H1N1 influenza infections
191: Emmanuel A. Burdmann: Leptospirosis
192: Emmanuel A. Burdmann: Syphilis
193: Emmanuel A. Burdmann and Vivekanand Jha: Rickettsiosis
194: Rashad S. Barsoum: Schistosomiasis
195: Raja Ramachandran and Vivekanand Jha: Nematode infections
196: John Eastwood, Catherine M. Corbishley, and John M. Grange: Mycobacterial infections: tuberculosis
197: John Eastwood, Catherine M. Corbishley, and John M. Grange: Mycobacterial infections: leprosy and environmental mycobacteria
198: Raja Ramachandran and Vivekanand Jha: Renal involvement in other infections
Part 9: The patient with urinary stone disease
199: Eric Taylor and Gary Curhan: Epidemiology of nephrolithiasis
200: Bhavna Chopra and Stanley Goldfarb: Approach to the patient with kidney stones
201: David A. Bushinsky and Orson Moe: Calcium stones
202: Michel Daudon and Paul Jungers: Uric acid stones
203: Michel Daudon and Paul Jungers: Cystine stones
204: Benjamin A. Vervaet and Marc E. De Broe: Cell biology of nephrocalcinosis/nephrolithiasis
205: Bridget Sinnott, Naim Maalouf, Khashayar Sakhaee, and Orson W. Moe: Medical management of nephrocalcinosis and nephrolithiasis
206: Gauthier Raynal and Olivier Traxer: Imaging and interventional treatment: urolithiasis from the surgeon>'s point of view
Part 10: The patient with hypertension
207: Karlhans Endlich and Rodger Loutzenhiser: The structure and function of renal blood vessels
208: Karlhans Endlich and Rodger Loutzenhiser: Regulation of vasomotor tone in the afferent and efferent arterioles
209: Karlhans Endlich and Rodger Loutzenhiser: Tubuloglomerular feedback and autoregulation of renal blood flow and glomerular filtration rate
210: O. Gonzalez-Albarrána and Luis M. Ruilopeb: The kidney and control of blood pressure
211: Ulrich Wenzel, Thorsten Wiech, and Udo Helmchen: The effect of hypertension on renal vasculature and structure
212: Helen Alderson, Constantina Chrysochou, James Ritchie, and Philip Kalra: Ischaemic nephropathy
213: James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra: Renal artery stenosis: clinical features and diagnosis
214: James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra: Renal artery stenosis: diagnosis
215: James Ritchie, Darren Green, Constantina Chrysochou, and Philip Kalra: Renal artery stenosis: management and outcome
216: Caroline Whitworth and Stewart Fleming: Malignant hypertension
217: David Webb and Ian MacIntyre: Resistant hypertension
218: Wolfgang Rascher: The hypertensive child
219: Wolfgang Rascher: Treatment of hypertension in children
Part 11: The patient with acute kidney injury (and critical care nephrology)
220: Eric AJ Hoste and John A. Kellum: Definitions, classification, epidemiology, and risk factors of acute kidney injury
221: Michael S. Goligorsky and Julien Maizel (with contributions by R Vasko, M Rabadi, and B Ratliff): Pathophysiology of acute kidney injury
222: Norbert Lameire, Raymond Vanholder and Wim Van Biesen: Clinical approach to the patient with acute kidney injury: diagnosis and differential diagnosis
223: Norbert Lameire: The role of novel biomarkers in acute kidney injury
224: Norbert Lameire: Prevention of acute kidney injury: overview
225: Norbert Lameire: Prevention of acute kidney injury: non-pharmacological strategies
226: Norbert Lameire: Prevention of acute kidney injury: pharmacological strategies
227: Norbert Lameire: Prevention of acute kidney injury: drug- and nephrotoxin-induced acute kidney injury
228: Achim Jörres, Dietrich Hasper, and Michael Oppert: Non-dialytic management of the patient with acute kidney injury
229: Achim Jörres, Dietrich Hasper, and Michael Oppert: Fluid overload
230: Achim Jörres, Dietrich Hasper, and Michael Oppert: Electrolyte and acid-base disorders
231: Achim Jörres, Dietrich Hasper, and Michael Oppert: Coagulation disturbances
232: Jang Won Seo and Ravindra L. Mehta: Renal replacement therapy in the patient with acute kidney injury: overview
233: Mark R Marshall: Intermittent acute renal replacement therapy
234: Miet Schetz and Andrew Davenport: Continuous renal replacement therapy
235: Wim Van Biesen: Peritoneal dialysis in acute kidney injury
236: Angel Candela, Teresa Tenorio, Aurora Lietor, and Fernando Liaño: Scoring systems in acute kidney injury patients
237: Norbert Lameire, Wim Van Biesen, and Raymond Vanholder: Short and long-term overall outcome and renal prognosis of AKI
238: Norbert Lameire: Overall and renal prognosis of AKI
239: Alexander Fichtner and Franz Schaefer: Acute kidney injury in children
240: Dinna N. Cruz, Anna Clementi, and Mitchell H. Rosner: Acute kidney injury in the elderly
241: Vivekanand Jha: Acute kidney injury in the tropics
242: Jan Clement and Piet Maes: Acute kidney injury and hantavirus disease
243: Norbert Lameire: Community-acquired pneumonia and acute kidney injury
244: John Prowle and Rinaldo Bellomo: Acute kidney injury in severe sepsis
245: Jeremiah R. Brown and Chirag R. Parikh: Cardiovascular surgery and acute kidney injury
246: Douglas Stewart, Gaurav Shah, Jeremiah R. Brown, and Peter A. McCullough: Contrast-induced acute kidney injury
247: Vicente Arroyo, Monica Guevara, and Javier Fernández: Renal failure in cirrhosis: pathogenesis, diagnosis, and treatment
248: Dinna N. Cruz, Anna Giuliani, and Claudio Ronco: Acute kidney injury in heart failure
249: Soo Young Yoon and Ravindra L. Mehta: Acute kidney injury in pulmonary diseases
250: Duska Dragun and Björn Hegner: Acute kidney injury in pregnancy
251: Gilbert W. Moeckel, Veena Manjunath, and Mark A. Perazella: Acute kidney injury in the cancer patient
252: Mehmet Sukru Sever and Raymond Vanholder: Acute kidney injury in polytrauma and rhabdomyolysis
253: Nele Brusselaers and Eric AJ Hoste: Acute kidney injury in patients with severe burn injury
VOLUME 3
Part 12: The patient on dialysis
254: Griet Glorieux, Nathalie Neirynck, Anneleen Pletinck, Eva Schepers, and Raymond Vanholder: Uraemic toxins: overview
255: Jonathan Himmelfarb: Haemodialysis: overview
256: Michael Allon: Haemodialysis: vascular access
257: Claudio Ronco and William R. Clark: Haemodialysis: principles
258: Scott D. Bieber and Jonathan Himmelfarb: Haemodialysis: prescription and assessment of adequacy
259: Victor F. Seabra and Bertrand L. Jaber: Hemodialysis: acute complications
260: Francesco Locatelli, Celestina Manzoni, and Giuseppe Pontoriero: Haemofiltration and haemodiafiltration
261: Arkadiy Pinkhasov, Michael J Germain, and Lewis M. Cohen: Dialysis withdrawal and palliative care
262: Alan S. Kliger and Rita Suri: Frequent haemodialysis
263: Rajnish Mehrotra and Jonathan Himmelfarb: Peritoneal dialysis: overview
264: Joanna Stachowska-Pietka, Jacek Waniewski, and Bengt Lindholm: Peritoneal dialysis: principles and peritoneal physiology
265: Anjali Bhatt Saxena: Peritoneal dialysis: adequacy and prescription management
266: Sara Dunsmore and Joanne Bargman: Peritoneal dialysis: non-infectious complications
267: Allen R. Nissenson, John Moran, and Robert Provenzano: Overview of dialysis patient management and future directions
268: Gerard M. London: Cardiovascular complications in end-stage renal disease patients: pathophysiological aspects
269: Laura Labriola, Michel Jadoul, and Eric Goffin: Bacterial and fungal infections in patients on haemodialysis
270: Laura Labriola, Michel Jadoul, and Eric Goffin: Bacterial and fungal infections in patients on peritoneal dialysis
271: Laura Labriola, Michel Jadoul, and Eric Goffin: Virus infections in patients on dialysis
272: Manjula Kurella Tamura, Mark L. Unruh, and Ea Wha Kang: Cognitive function, depression, and psychosocial adaptation
273: Rajiv Agarwal: Volume assessment and management in dialysis
274: Carla Maria Avesani, Juan Jesús Carrero, Bengt Lindholm, and Peter Stenvinkel: Nutritional screening and nutritional management in dialysis patients
Part 13: The transplant patient
275: Peter J Morris and Jeremy R Chapman: The evolution of kidney transplantation
276: Christophe Legendre: Pre-transplant assessment of the recipient
277: Thomas Mone: Organ donation
278: Richard DM Allen and Henry CC Pleass: Donor and recipient kidney transplantation surgery
279: Thangamani Muthukumar, Darshana Dadhania, Choli Hartono, Manikkam Suthanthiran, and Choli Hartono: Immunology, sensitization, and histocompatibility
280: Simon R Knight and Rutger J Ploeg: Immediate post-transplant care and surgical complications
281: Dirk R J Kuypers and Maarten Naesens: Immunosuppression, drugs, and protocols
282: Simon Gruenewald and Philip Vladica: Renal transplant imaging
283: David N. Rush and Peter W. Nickerson: Rejection
284: Camille Nelson Kotton: Infection: prophylaxis, diagnosis, and management
285: Emily P McQuarrie, Hallvard Holdaas, Bengt Fellström, and Alan G Jardine: Cardiovascular disease: prophylaxis, diagnosis, and management
286: L.K. Henderson, B.J. Nankivell, and J.R. Chapman: Chronic allograft dysfunction
287: Germaine Wong and Angela C Webster: Cancer after kidney transplantation
288: Grahame J Elder: Metabolic bone disease: prophylaxis, diagnosis, and management
289: Philip Clayton and Steven Chadban: Recurrent renal disease: prophylaxis, diagnosis, and management
290: Minnie M. Sarwal and Ron Shapiro: Paediatric renal transplantation
Part 14: Renal disease at different stages of life
291: Lesley Rees: Growth and development
292: Stephen D Marks: The adolescent with renal disease: transition to adult services
293: Kate Wiles and Catherine Nelson-Piercy: Contraception in patients with kidney disease
294: Kate Bramham and Catherine Nelson-Piercy: Pregnancy and renal physiology
295: Kate Bramham and Catherine Nelson-Piercy: Pregnancy in patients with chronic kidney disease and on dialysis
296: Kate Wiles and Catherine Nelson-Piercy: Pre-eclampsia and related disorders
297: Kate Wiles and Catherine Nelson-Piercy: Acute renal disease in pregnancy
298: Kate Bramham and Catherine Nelson-Piercy: Specific renal conditions in pregnancy
299: Kate Bramham and Catherine Nelson-Piercy: Pregnancy after renal transplantation
300: Richard J. Glassock and Andrew D. Rule: The kidney in ageing: biology, anatomy, physiology, and clinical relevance
Part 15: The patient with genetic renal disease
301: Frances Flinter: Ethical aspects of genetic testing
302: Frances Flinter: Antenatal diagnosis and pre-implantation genetic testing
303: Wolfgang Kühn and Gerd Walz: The molecular basis of ciliopathies and cyst formation
304: Yves Pirson and Olivier Devuyst: The adult with renal cysts
305: Carsten Bergmann, N. Ortis-Bruchle, V. Frank, and Klaus Zerres: The child with renal cysts
306: Albert CM Ong and Richard Sandford: Autosomal dominant polycystic kidney disease: overview
307: Albert CM Ong and Timothy Ellam: Autosomal dominant polycystic kidney disease: clinical features
308: Richard Sandford: Autosomal dominant polycystic kidney disease: diagnosis
309: Young-Hwan Hwang and York Pei: Autosomal dominant polycystic kidney disease: management (including strategies to slow progression)
310: Yves Pirson and Dominique Chauveau: Management of intracranial aneurysms
311: Joost Drenth and Tom Gevers: Management of cystic liver disease
312: Carsten Bergmann and Klaus Zerres: Autosomal dominant polycystic kidney disease in children and young adults
313: Carsten Bergmann and Klaus Zerres: Autosomal recessive polycystic kidney disease
314: Lukas Foggensteiner and Philip Beales: Bardet-Biedl syndrome and other ciliopathies
315: Coralie Bingham: Hepatocyte nuclear factor-1B
316: John A Sayer: Nephronophthisis and medullary cystic kidney disease: overview
317: John A Sayer and Roslyn J Simms: Nephronophthisis
318: John A Sayer: Medullary cystic kidney disease and other autosomal dominant inherited interstitial kidney diseases
319: Brunella Franco: Oral-facial-digital type 1 syndrome
320: Rachel Lennon and Neil Turner: The molecular basis of glomerular basement membrane disorders
321: Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler: Alport syndrome: overview
322: Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler: Alport syndrome: clinical features
323: Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler: Alport syndrome: diagnosis
324: Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler: Alport syndrome: management
325: Laurence Heidet, Bertrand Knebelmann, and Marie Claire Gubler: Thin glomerular basement membrane nephropathy and other collagenopathies
326: Laurence Heidet and Marie Claire Gubler: Nail patella syndrome
327: Moin A. Saleem and Corinne Antignac: Molecular basis of nephrotic syndrome
328: Tom Connor and Patrick Maxwell: Molecular basis of renal tumour syndromes
329: Nick Hastie and Eve Miller-Hodges: WT1 and its disorders
330: Bradley P. Dixon, J. Christopher Kingswood, and John J. Bissler: Tuberous sclerosis complex renal disease
331: Tom Connor and Patrick Maxwell: Hypoxia-inducible factor and renal disorders
332: Tom Connor and Patrick Maxwell: Von Hippel-Lindau disease
333: Nicholas Medjeral-Thomas, Anna Richards, and Matthew C. Pickering: Molecular basis of complement-mediated renal disease
334: Robin Lachmann and Elaine Murphy: Inherited metabolic diseases and the kidney
335: Stephen Waldek: Fabry disease: overview and pathophysiology
336: Stephen Waldek: Fabry disease: clinical features
337: Stephen Waldek: Fabry disease: diagnosis
338: Stephen Waldek: Fabry disease: management and outcome
339: Elena N. Levtchenko and Mirian C. Janssen: Cystinosis
340: Andrew Hall and Shamima Rahman: Mitochondrial diseases and the kidney
341: Neil Turner, Teena Tandon, and Rajiv Agarwal: APOL1 and renal disease
342: Neil Turner and Bertrand Knebelmann: MYH9 and renal disease
Part 16: The patient with structural and congenital abnormalities
343: Paul Winyard: Human kidney development
344: Oren Pleniceanu and Benjamin Dekel: Kidney stem cells
345: Michiel Schreuder: Anatomical types of congenital anomalies: overview of obstruction
346: Michiel Schreuder: Renal agenesis
347: Michiel Schreuder: Renal dysplasia
348: Michiel Schreuder: Renal hypoplasia
349: Michiel Schreuder: Normal variation in nephron numbers
350: Michiel Schreuder: Renal tubular dysgenesis
351: Michiel Schreuder: Congenital solitary functioning kidney
352: Michiel Schreuder: Duplex, ectopic, and horseshoe kidneys
353: Michiel Schreuder: Pelviureteric junction obstruction and megaureter
354: Michiel Schreuder: Posterior urethral valves
355: Heather Lambert: Vesicoureteric reflux and reflux nephropathy
356: Muhammad M. Yaqoob, Katherine Bennett-Richards, and Islam Junaid: The patient with urinary tract obstruction
357: Muhammad M. Yaqoob, Katherine Bennett-Richards, and Islam Junaid: Retroperitoneal fibrosis
358: Udo Vester and Stefanie Weber: Branchio-oto-renal syndrome
359: Udo Vester and Stefanie Weber: Townes-Brocks syndrome
360: Udo Vester and Stefanie Weber: Renal coloboma syndrome
361: Fred E. Avni, Marie Cassart, Anne Massez, and Michèle Hall: Ante- and postnatal imaging to diagnose human kidney malformations
Part 17: Drugs and renal disease
362: Anushree Shirali and Mark A. Perazella: Drug-induced nephropathies
363: Ali J. Olyaei, Ted A. Foster, and Edgar V. Lerma: Drug dosing in chronic kidney disease
364: Thomas A. Golper, Andrew A. Udy, and Jeffrey Lipman: Drug dosing in acute kidney injury